MIR183 (microRNA 183; HGNC:31554, NCBI Gene 406959) is the gene on chromosome 7q32.2 encoding miR-183 — the lead member of the miR-183~96~182 sensory cluster: the homeostatic-feedback miRNA of sensory receptors (expressed in hair cells, photoreceptors, and the sensory ganglia), repressing its own pathway's genes to tune receptor sensitivity — and a metastasis-suppressor file in prostate and colon cancers.
Approved Symbol
MIR183 (HGNC:31554)
Chromosomal Locus
7q32.2 (the miR-183~96~182 cluster)
Encoded Product
A 22-nt mature microRNA, the sensory-cluster lead
Primary Pathway
Sensory-receptor program + homeostatic feedback (the receptor's own sensitivity genes repressed)
Clinical / Therapeutic Role
Sensory biology; prostate and colon metastasis-suppressor file
Gene Structure & Expression
Structure: The cluster's first hairpin (miR-96 and miR-182 following) — one pri-miRNA, three seeds, the sensory lineage's identity marker.
Expression: Sensory epithelia and the sensory-ganglion file; paradoxically re-expressed in some cancers (the metastasis contexts cutting both ways).
Homeostasis depth: The sensory-adaptation experiments (the Weber-Fechner-adjacent gain control) established miR-183 as the receptor's own sensitivity tuner — the operating-point concept that gave the cluster its biology beyond marker status. The prostate file (the ezrin-adjacent metastasis targets) shows the same seed in an unrelated program.
Comparative: The cancer and sensory files sharing one seed — the cell-context lesson again, miR-96's DFNA50 file the human-disease proof.
Sensory homeostasis: The landmark finding — miR-183's repression of multiple sensory-pathway genes (the mechanotransduction channel-adjacent program) tuning receptor sensitivity in the adaptation state: the first microRNA shown to set a sensory neuron's operating point, miR-96's DFNA50 file the human proof of importance.
Cancer file: The prostate metastasis-suppressor data (miR-183 loss with ezrin/ezrin-adjacent targets) and the colon contexts — the sensory miRNA moonlighting in tumor progression.
Clinical & Therapeutic Significance
Biomarker: The cluster in prostate and colon panels; the sensory expression making it a hair-cell and photoreceptor marker, retina.
Comparative: The cluster's conservation from zebrafish neuromasts to human cochlea — the cell-identity case in the miRNA textbooks.